ATH
Click for more information
11.1% 0.4¢ alterity therapeutics limited

Research AD biomarkers to routine diagnostics, page-5

  1. m123456
    1,640 Posts.
    lightbulb Created with Sketch. 143
    clock Created with Sketch.
    15/03/21
    11:26
    Post #: 51768287
    ?? Pbt2 is worth way more than 3c or 4c a share. Why would alteriry sell it? I bet it they did it would be straight back into trials for AD and the dog concerns would disappear
    Last edited by m123456: 15/03/21
    ATH Price at posting: 3.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
RHK Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢ 		Change
-0.001(11.1%) 		Mkt cap ! $21.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $1.528K 317.5K

Buyers (Bids)

No. Vol. Price($)
102 97511267 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31179254 15
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.